CAFs Enhance Adenosine Production in NSCLC, Impeding T Cell Response
Cancer-associated fibroblasts (CAFs) promote the expression of CD39 and CD73 on T cells, leading to increased adenosine synthesis, which may facilitate tumor immune evasion.
Phase III
non-small cell lung cancer (NSCLC)
Status
Active
Signal Score
8.4
Signal assessment
Signal strength
high
Confidence level
high
Why it matters
The findings reveal a significant mechanism of immune suppression in NSCLC, highlighting the role of CAFs in promoting adenosine production that impedes T cell responses. This presents an opportunity for pharma companies to explore novel therapeutic strategies targeting CAF-T cell interactions to enhance immune responses in cancer treatment.
Recommended action
Humanexa recommends Investigate.
Analysis
Monitor developments in therapies targeting the adenosine pathway and CAF interactions in NSCLC clinical trials.
Related companies & assets
Sources & Humanexa intelligence
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.